AstraZenca is getting a jump on the University of Oxford’s COVID-19 vaccine by starting to manufacture the vaccine even though clinical trial results for it aren’t expected to be released until July or August.
The drug company’s CEO, Pascal Soriot, said “the company wasn’t going to wait for clinical results,” and that they’d already signed agreements to supply the vaccine to low- and middle-income countries through health organizations, two of which are backed by Bill Gates.
Human clinical trials for this vaccine only started a few weeks ago, at the end of April.
SOURCE: MarketWatch June 5, 2020